HALEON UK HOLDINGS (NO.3) LIMITED

Company number 13401293

Date	Type	Description	View / Download
20 Oct 2023	PSC05	Change of details for Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 20 October 2023	(2 pages)
17 Oct 2023	PSC05	Change of details for Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 19 July 2022	(2 pages)
22 Sep 2023	AA	Full accounts made up to 31 December 2022	(24 pages)
18 Aug 2023	CERTNM	Company name changed gsk consumer healthcare holdings (no.3) LIMITED\certificate issued on 18/08/23 NM01 ‐ Change of name by resolution RES15 ‐ Change company name resolution on 2023-08-02	(3 pages)
05 Jun 2023	CH02	Director's details changed for Haleon Uk Corporate Secretary Limited on 18 July 2022	(1 page)
05 Jun 2023	CH02	Director's details changed for Haleon Uk Corporate Director Limited on 18 July 2022	(1 page)
31 May 2023	AP01	Appointment of Mr Thomas Whittle as a director on 11 May 2023	(2 pages)
23 May 2023	CS01	Confirmation statement made on 15 May 2023 with updates	(4 pages)
17 May 2023	CH02	Director's details changed for Gsk Consumer Healthcare Holdings No.8 Limited on 31 March 2023	(1 page)
17 May 2023	CH02	Director's details changed for Gsk Consumer Healthcare Holdings No.4 Limited on 31 March 2023	(1 page)
28 Apr 2023	TM01	Termination of appointment of David Christopher Senior as a director on 14 April 2023	(1 page)
03 Oct 2022	AA	Full accounts made up to 31 December 2021	(23 pages)
29 Jul 2022	PSC07	Cessation of Glaxosmithkline Consumer Healthcare Holdings (No.2) Limited as a person with significant control on 14 July 2022	(1 page)
29 Jul 2022	PSC02	Notification of Glaxosmithkline Consumer Healthcare Holdings Limited as a person with significant control on 14 July 2022	(2 pages)
18 Jul 2022	AD01	Registered office address changed from 980 Great West Road Brentford TW8 9GS England to Building 5, First Floor the Heights Weybridge Surrey KT13 0NY on 18 July 2022	(1 page)
15 Jun 2022	CS01	Confirmation statement made on 15 May 2022 with updates	(4 pages)
06 Apr 2022	TM01	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 6 April 2022	(1 page)
06 Apr 2022	AP02	Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 6 April 2022	(2 pages)
06 Apr 2022	TM01	Termination of appointment of the Wellcome Foundation Limited as a director on 6 April 2022	(1 page)
06 Apr 2022	AP02	Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022	(2 pages)
09 Mar 2022	TM01	Termination of appointment of John Michael Sadler as a director on 4 March 2022	(1 page)
09 Mar 2022	AP01	Appointment of Mr Khalid El Ansari as a director on 4 March 2022	(2 pages)
09 Mar 2022	AP01	Appointment of Mr David Christopher Senior as a director on 4 March 2022	(2 pages)
31 Dec 2021	PSC02	Notification of Glaxosmithkline Consumer Healthcare Holdings (No.2) Limited as a person with significant control on 22 November 2021	(2 pages)
31 Dec 2021	PSC07	Cessation of Consumer Healthcare Holdings Limited as a person with significant control on 22 November 2021	(1 page)